Norway Savings Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Buy
4,919
+263
+6% +$148K 1.09% 31
2026
Q1
$2.62M Buy
4,656
+25
+0.5% +$16K 1.24% 27
2025
Q4
$3.13M Buy
4,631
+941
+26% +$641K 1.45% 21
2025
Q3
$2.36M Sell
3,690
-42
-1% -$25.5K 1.14% 30
2025
Q2
$2M Buy
3,732
+294
+9% +$141K 1.03% 34
2025
Q1
$1.44M Buy
3,438
+131
+4% +$56.9K 0.82% 42
2024
Q4
$1.37M Sell
3,307
-85
-3% -$37.3K 0.76% 45
2024
Q3
$1.71M Sell
3,392
-53
-2% -$25.7K 0.93% 36
2024
Q2
$1.68M Sell
3,445
-204
-6% -$102K 0.96% 33
2024
Q1
$1.97M Sell
3,649
-76
-2% -$41.5K 0.82% 44
2023
Q4
$2.07M Buy
3,725
+60
+2% +$28.2K 0.92% 38
2023
Q3
$1.6M Buy
3,665
+30
+0.8% +$15K 0.79% 45
2023
Q2
$1.83M Buy
3,635
+188
+5% +$90.1K 1% 32
2023
Q1
$1.72M Buy
3,447
+60
+2% +$28.7K 0.87% 41
2022
Q4
$1.38M Buy
3,387
+151
+5% +$58.6K 0.7% 52
2022
Q3
$1.05M Buy
3,236
+700
+28% +$257K 0.57% 61
2022
Q2
$889K Buy
2,536
+262
+12% +$107K 0.46% 71
2022
Q1
$1.24M Buy
2,274
+167
+8% +$87.8K 0.56% 63
2021
Q4
$1.39M Buy
2,107
+40
+2% +$25.1K 0.61% 57
2021
Q3
$1.28M Buy
2,067
+38
+2% +$25.5K 0.61% 56
2021
Q2
$1.28M Buy
2,029
+80
+4% +$44.2K 0.62% 53
2021
Q1
$954K Sell
1,949
-86
-4% -$43.1K 0.5% 64
2020
Q4
$1.02M Buy
2,035
+26
+1% +$11.6K 0.58% 58
2020
Q3
$790K Sell
2,009
-25
-1% -$9.24K 0.53% 59
2020
Q2
$672K Buy
2,034
+215
+12% +$62.3K 0.49% 61
2020
Q1
$440K Buy
1,819
+239
+15% +$62.4K 0.38% 72
2019
Q4
$413K Buy
1,580
+75
+5% +$19.8K 0.3% 80
2019
Q3
$410K Sell
1,505
-15
-1% -$4.17K 0.33% 75
2019
Q2
$418K Sell
1,520
-20
-1% -$4.93K 0.36% 70
2019
Q1
$344K Sell
1,540
-50
-3% -$10.3K 0.3% 76
2018
Q4
$296K Sell
1,590
-20
-1% -$4.1K 0.29% 73
2018
Q3
$402K Sell
1,610
-410
-20% -$99.5K 0.35% 67
2018
Q2
$441K Sell
2,020
-40
-2% -$8.24K 0.4% 61
2018
Q1
$394K Sell
2,060
-45
-2% -$8.3K 0.37% 67
2017
Q4
$329K Sell
2,105
-50
-2% -$7.87K 0.31% 72
2017
Q3
$335K Hold
2,155
0.32% 72
2017
Q2
$348K Sell
2,155
-105
-5% -$17.1K 0.34% 71
2017
Q1
$349K Sell
2,260
-2,850
-56% -$393K 0.36% 69
2016
Q4
$599K Buy
+5,110
New +$583K 0.56% 57

Other funds holding IDXX

Norway Savings Bank's IDXX Position: Q2 2026 in Review

Norway Savings Bank increased its Idexx Laboratories (IDXX) stake by 5.6% in Q2 2026, buying an estimated $148K and bringing the position to 4,919 shares worth $2.59M. The position accounts for 1.09% of the portfolio, ranked #31.

Norway Savings Bank first reported a position in IDXX in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.13M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Norway Savings Bank held 4,919 shares of Idexx Laboratories worth $2.59M as of Q2 2026.
  • Norway Savings Bank bought 263 Idexx Laboratories shares in Q2 2026, an estimated $148K.
  • Idexx Laboratories made up 1.09% of Norway Savings Bank's portfolio in Q2 2026, its #31 holding.
  • Norway Savings Bank first reported a position in Idexx Laboratories in Q4 2016 and has held it in 39 quarters since.
  • Norway Savings Bank's Idexx Laboratories position peaked at $3.13M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.